Extracellular and subcellular regulation of the PI3K/Akt cassette: new mechanisms for controlling insulin and growth

C Wilson1, N Vereshchagina, B Reynolds

  • 1Department of Physiology, Anatomy and Genetics, Le Gros Clark Building, University of Oxford, Oxford, UK. clive.wilson@dpag.ox.ac.uk

Insights

New fruitfly studies reveal nutrient transporters and Akt kinase distribution regulate phosphoinositide 3-kinase/Akt signaling. These findings offer insights into insulin resistance and potential treatments for linked diseases.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The phosphoinositide 3-kinase (PI3K)/Akt signaling pathway is crucial for cellular responses to growth factors, especially insulin-like molecules.
  • Dysregulation of PI3K/Akt signaling is implicated in diabetes and various human cancers.

Purpose of the Study:

  • To identify novel mechanisms regulating PI3K/Akt signaling using molecular genetic studies in Drosophila melanogaster.
  • To explore the influence of extracellular nutrients and subcellular Akt distribution on PI3K/Akt pathway activity.

Main Methods:

  • Molecular genetic analysis in Drosophila melanogaster.
  • Investigation of cell-surface transporters and sensors.
  • Analysis of subcellular localization of activated Akt kinase.

Main Results:

  • Cell-surface transporters and sensors modulate cellular responses to PI3K/Akt signaling, highlighting the role of extracellular nutrients in insulin sensitivity.
  • Different cell types exhibit distinct subcellular distributions of activated Akt, impacting its cellular functions.
  • Two novel cell-type-specific regulatory mechanisms of PI3K/Akt signaling were identified.

Conclusions:

  • Extracellular nutrients and the subcellular localization of Akt kinase are key regulators of PI3K/Akt signaling.
  • These findings provide new insights into the differential regulation of growth, lipogenesis, and insulin resistance.
  • The identified mechanisms may suggest novel therapeutic strategies for insulin-related diseases.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...